Loading...

BioSyent Inc.

BIOYF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$10.88
$0.01(0.09%)
U.S. Market opens in 14h 21m

BioSyent Inc. (BIOYF) Stock Overview

Explore BioSyent Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap125.1M
P/E Ratio18.68
EPS (TTM)$0.57
ROE0.23%
Fundamental Analysis

AI Price Forecasts

1 Month$11.17
3 Months$13.47
1 Year Target$10.63

BIOYF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of BioSyent Inc. (BIOYF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 53.48, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $10.63.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 18.68 and a market capitalization of 125.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.09%
5-Day Change
2.93%
1-Month Change
-4.23%
3-Month Change
16.74%
6-Month Change
31.08%
Year-to-Date (YTD) Change
14.29%
1-Year Change
47.83%
3-Year Change
88.24%
5-Year Change
76.91%
All-Time (Max) Change
1573.85%

Contact Information

https://www.biosyent.com
905-206-0013
2476 Argentia Road, Mississauga, ON, L5N 6M1

Company Facts

60 Employees
IPO DateFeb 22, 2012
CountryCA
Actively Trading

Frequently Asked Questions